World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
106
Citations
44515
World Ranking
6488
National Ranking
181

Ian Jacobs publications per year

1979: 1 publications 1980: 0 publications 1981: 0 publications 1982: 0 publications 1983: 0 publications 1984: 0 publications 1985: 0 publications 1986: 0 publications 1987: 1 publications 1988: 8 publications 1989: 2 publications 1990: 5 publications 1991: 2 publications 1992: 2 publications 1993: 7 publications 1994: 5 publications 1995: 4 publications 1996: 8 publications 1997: 2 publications 1998: 7 publications 1999: 17 publications 2000: 26 publications 2001: 24 publications 2002: 12 publications 2003: 18 publications 2004: 31 publications 2005: 16 publications 2006: 22 publications 2007: 30 publications 2008: 25 publications 2009: 29 publications 2010: 38 publications 2011: 22 publications 2012: 28 publications 2013: 24 publications 2014: 19 publications 2015: 27 publications 2016: 26 publications 2017: 26 publications 2018: 14 publications 2019: 16 publications 2020: 13 publications 2021: 18 publications 2022: 3 publications 2023: 70 publications 2024: 2 publications 2025: 3 publications
1979 2025

653 publications in total across all disciplines

Ian Jacobs publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ian Jacobs sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 554 publications — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Ian Jacobs D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ian Jacobs sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 106 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Ian Jacobs is affiliated with the University of New South Wales in Australia. Their research primarily focuses on medicine, with significant contributions in biochemistry, genetics, and molecular biology. The work covers a range of subfields including reproductive medicine, genetics, oncology, obstetrics and gynecology, and cancer research.

Their research topics predominantly address ovarian cancer diagnosis and treatment, followed by investigations into BRCA gene mutations in cancer, endometrial and cervical cancer treatments, colorectal cancer screening and detection, genetic associations and epidemiology, endometriosis research and treatment, and cancer genomics and diagnostics.

Several recent papers illustrate the scope and focus of their research:

  • Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial (2021), The Lancet
  • Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D (2020), JNCI Journal of the National Cancer Institute
  • Improved early detection of ovarian cancer using longitudinal multimarker models (2020), British Journal of Cancer
  • Ovarian cancer symptoms, routes to diagnosis and survival - Population cohort study in the 'no screen' arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) (2020), Gynecologic Oncology
  • Comprehensive epithelial tubo-ovarian cancer risk prediction model incorporating genetic and epidemiological risk factors (2021), Journal of Medical Genetics

Frequent co-authors collaborating with Ian Jacobs include Usha Menon, Aleksandra Gentry-Maharaj, Matthew Burnell, Andy Ryan, and Jatinderpal Kalsi. These collaborations have led to a substantial number of joint publications spanning clinical trials, genetics, and epidemiological studies.

Their work has been published in several notable academic venues, most frequently in:

  • Cancers
  • bioRxiv (Cold Spring Harbor Laboratory)
  • BJOG An International Journal of Obstetrics & Gynaecology
  • Gynecologic Oncology
  • Health Technology Assessment

Ian Jacobs' research output shows a strong emphasis on cancer-related diseases, particularly ovarian cancer, addressing both clinical and genetic aspects. Their interdisciplinary approach spans diagnostics, treatment, risk prediction, and population screening strategies within the broader field of reproductive medicine and oncology.

Best Publications

  • The CA 125 tumour-associated antigen: a review of the literature

    Ian Jacobs;Robert C. Bast

  • A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer

    I Jacobs;D Oram;J Fairbanks;J Turner

  • Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer

    Zhen Zhang;Robert C. Bast;Yinhua Yu;Jinong Li

  • Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.

    Ian J Jacobs;Ian J Jacobs;Ian J Jacobs;Usha Menon;Andy Ryan;Aleksandra Gentry-Maharaj

  • Epigenetic stem cell signature in cancer.

    Martin Widschwendter;Heidi Fiegl;Heidi Fiegl;Daniel Egle;Elisabeth Mueller-Holzner

  • Menarche, menopause, and breast cancer risk: Individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies

    N. Hamajima;K. Hirose;K. Tajima;T. Rohan

  • Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer

    Andrew E. Teschendorff;Usha Menon;Aleksandra Gentry-Maharaj;Susan J. Ramus

  • Management of women who test positive for high-risk types of human papillomavirus: The HART study

    Jack Cuzick;A Szarewski;H Cubie;G Hulman

  • Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: Results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

    Usha Menon;Aleksandra Gentry-Maharaj;Rachel Hallett;Andy Ryan

  • SCREENING FOR OVARIAN CANCER : A PILOT RANDOMISED CONTROLLED TRIAL

    Ian J. Jacobs;Steven J. Skates;Nicola MacDonald;Usha Menon

  • Ovarian Cancer Population Screening and Mortality After Long-Term Follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): A Randomised Controlled Trial

    Usha Menon;Aleksandra Gentry-Maharaj;Matthew Burnell;Naveena Singh

  • Progress and Challenges in Screening for Early Detection of Ovarian Cancer

    Ian J. Jacobs;Usha Menon

  • New tumor markers: CA125 and beyond

    Robert C. Bast;D. Badgwell;Z. Lu;R. Marquez

  • Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence

    N. Hamajima;K. Hirose;K. Tajima;T. Rohan

  • Controlling Molecular Doping in Organic Semiconductors

    Ian E. Jacobs;Adam J. Moulé

  • Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.

    Ian Jacobs;Ann Prys Davies;Jane Bridges;Isabel Stabile

  • Part 1: Executive summary: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.

    Mary Fran Hazinski;Jerry P. Nolan;John E. Billi;Bernd W. Böttiger

  • Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer

    Susan J. Ramus;Honglin Song;Ed Dicks;Jonathan P. Tyrer

  • Diagnostic Performance of Nanoparticle-Enhanced Magnetic Resonance Imaging in the Diagnosis of Lymph Node Metastases in Patients With Endometrial and Cervical Cancer

    Andrea G. Rockall;Syed A. Sohaib;Mukesh G. Harisinghani;Syed A. Babar

  • PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma.

    Helga B. Salvesen;Helga B. Salvesen;Nicola MacDonald;Andy Ryan;Ian J. Jacobs

Frequent Co-Authors

Usha Menon
Usha Menon University College London
Susan J. Ramus
Susan J. Ramus University of New South Wales
Martin Widschwendter
Martin Widschwendter University College London
Robert C. Bast
Robert C. Bast The University of Texas MD Anderson Cancer Center
Lesley Fallowfield
Lesley Fallowfield University of Sussex
Alistair McGuire
Alistair McGuire London School of Economics and Political Science
Andrew Berchuck
Andrew Berchuck Duke University
Andrew M. Ryan
Andrew M. Ryan University of Michigan–Ann Arbor
Susanne K. Kjaer
Susanne K. Kjaer University of Copenhagen
Paul D.P. Pharoah
Paul D.P. Pharoah University of Cambridge

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in medicine but aren’t ready for medical school, there are plenty of related online degrees and career pathways to explore. Online nursing programs, for instance, offer flexible, accessible options for both aspiring and current nurses. Those who are already registered nurses might consider the cheapest rn to bsn online programs to further their education affordably.

Non-nurses interested in an advanced degree may want to look into online msn programs for non nurses, which provide a direct route to high-level nursing careers. Alternatively, if your goal is to enter the nursing field without prior experience, there are online bsn programs for non nurses that offer accessible entry points.

For those drawn to the administrative side of healthcare, medical billing and coding remains in high demand. Many pursue certifications through the best medical billing and coding schools online, often with the help of financial aid. Each of these pathways can open doors to rewarding healthcare careers without committing to a traditional medical degree.

Best Scientists Citing Ian Jacobs

Trending Scientists

Recently Published Articles